Establishment Labs Holdings Inc.
ESTA Nasdaq· Orthopedic, Prosthetic & Surgical Appliances & Supplies
Last close · Oct 23, 2026
$63.80
KIRA · Stoqly’s AI analyst, in plain words
- Establishment Labs Holdings Inc. had $211M of revenue in fiscal 2025, up 27.1% on the year before. Over five years, revenue changed +20.0% a year on average.
- Its operating margin was −18.5%, up 11.6 pts: of every 100 in sales, about −18 is left after running the business.
- Establishment Labs Holdings Inc. lost $51.1M in fiscal 2025.
- Free cash flow was −$56.9M in fiscal 2025, −27.0% of revenue.
- Establishment Labs Holdings Inc. owes $172M more than it holds in cash.
Market cap
$1.9B
P/E
—
Revenue
$211M
Net income
−$51.1M
Free cash flow
−$56.9M
Operating margin
−18.5%
Establishment Labs Holdings Inc. in 30 seconds · fiscal 2025
Are sales growing?
+27.1%
Yes. Sales grew 27.1% last year.
Does it make a profit?
−24.2%
No. It lost money last year.
Does profit turn into cash?
−27.0%
No. It spent more cash than it brought in.
How healthy are the accounts?
4 / 9
Mixed. It passes 4 of 9 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Establishment Labs Holdings Inc. does
No business description yet.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 27, 2026
- Legal name
- ESTABLISHMENT LABS HOLDINGS INC.
- CIK
- 0001688757
Establishment Labs Holdings Inc. · ESTA
Results and finances
The last 5 fiscal years. Amounts in USD.
| Fiscal year | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Sales and profit | |||||
| Revenue | $127M | $162M | $165M | $166M | $211M |
| Revenue growth | 49.6% | 27.6% | 2.1% | 0.5% | 27.1% |
| Gross margin | 67.4% | 65.9% | 64.8% | 66.0% | 69.3% |
| Operating margin | −19.8% | −24.5% | −39.4% | −30.1% | −18.5% |
| Net income | −$41.1M | −$75.2M | −$78.5M | −$84.6M | −$51.1M |
| Net margin | −32.5% | −46.5% | −47.5% | −51.0% | −24.2% |
| Diluted EPS | −$1.72 | −$3.08 | −$3.07 | −$3.00 | −$1.72 |
| Cash | |||||
| Cash from operations | −$27.5M | −$52.2M | −$88.5M | −$58.5M | −$50.9M |
| Capital expenditure | $2.4M | $2.9M | $7.9M | $6.1M | $6.0M |
| Free cash flow | −$30.0M | −$55.0M | −$96.4M | −$64.6M | −$56.9M |
| FCF margin | −23.6% | −34.0% | −58.4% | −38.9% | −27.0% |
| Share count change | 2.8% | 2.0% | 4.7% | 10.0% | 5.2% |
| Debt and strength | |||||
| Cash and short-term investments | $53.4M | $66.4M | $40.0M | $90.3M | $75.6M |
| Debt incl. finance leases | $51.9M | $175M | $189M | $0.0M | $248M |
| Shareholders' equity | $50.7M | −$8.2M | $18.4M | $53.1M | $23.5M |
| Current ratio | 3.6x | 3.8x | 3.1x | 3.6x | 3.0x |
| Interest coverage | −2.8x | −3.4x | −4.2x | −2.4x | −1.5x |
| Returns and quality | |||||
| Return on capital | −40.3% | −31.0% | −30.7% | — | −15.8% |
| Return on equity | −65.5% | −353.5% | −1,537.7% | −236.7% | −133.3% |
| Return on tangible equity | −89.6% | — | −789.5% | −210.4% | −411.9% |
| Piotroski F-score | 3 | 2 | 2 | 5 | 4 |
| Altman Z'' | −1.6 | −2.2 | −3.0 | −1.7 | −2.1 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$36.9M
6 insiders
Of sales under plans
62%
$22.9M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Establishment Labs Holdings Inc. · ESTA
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $63.80 a share, the company is worth $1.9B.
Source: SEC EDGAR XBRL filings (CIK 0001688757). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.